News
The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...
According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, ...
2d
Us Weekly on MSNThe federal ban on generic GLP-1 starts this month. Here's what you can doIf you're following the GLP-1 (Ozempic and other prescription weight-loss medications) scene, you may have read that the FDA ...
News Evidence That GLP-1 Drugs Achieve Weight Loss Primarily by Reducing Fat Mass More Than Muscle. Diabetes and obesity have become pressing health issues worldwide. Glucagon-lik ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in ...
You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...
Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today an advancement in the use of artificial intelligence (AI) to scale the generation of ...
Patients with diabetes mellitus who use GLP-1 RAs have an increased risk for acute and chronic pancreatitis, according to a study presented at DDW 2025.
Neurologist Dr. Leah Croll talks about the new research suggesting they might help in treating people with alcohol use ...
When it came to cardiovascular incidents, the report showed major gains for GLP-1 users, too. 44% experienced fewer ...
5d
CivicScience on MSNGLP-1 Trends by CivicScience: Costs and Coverage Emerge as a Barrier Amid Uncertainty, But Emotional Wellbeing ImprovesExplore CivicScience insights on GLP-1 trends—costs emerge as a barrier, but users report improved emotional wellbeing. See ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results